Addex Therapeutics (ADXN) Gross Margin: 2022-2025
Historic Gross Margin for Addex Therapeutics (ADXN) over the last 3 years, with Jun 2025 value amounting to 100.00%.
- Addex Therapeutics' Gross Margin fell 278.00% to 100.00% in Q2 2025 from the same period last year, while for Jun 2025 it was 100.07%, marking a year-over-year increase of 2020.00%. This contributed to the annual value of 95.61% for FY2024, which is 1615.00% up from last year.
- Addex Therapeutics' Gross Margin amounted to 100.00% in Q2 2025, which was down 0.38% from 100.38% recorded in Q1 2025.
- In the past 5 years, Addex Therapeutics' Gross Margin ranged from a high of 102.78% in Q2 2024 and a low of -19,315,767.26% during Q1 2022.
- In the last 3 years, Addex Therapeutics' Gross Margin had a median value of 95.78% in 2023 and averaged -86,787.88%.
- Its Gross Margin has fluctuated over the past 5 years, first soared by 1,844,738,543bps in 2023, then crashed by 29,485bps in 2024.
- Over the past 4 years, Addex Therapeutics' Gross Margin (Quarterly) stood at 100.00% in 2022, then tumbled by 5,949bps to 40.51% in 2023, then soared by 5,949bps to 100.00% in 2024, then slumped by 278bps to 100.00% in 2025.
- Its Gross Margin stands at 100.00% for Q2 2025, versus 100.38% for Q1 2025 and 100.00% for Q4 2024.